Molecular Imaging and Radionuclide Therapy Q3 Unclaimed
Galenos Publishing House
Turkey
Molecular Imaging and Radionuclide Therapy is a journal indexed in SJR in Radiology, Nuclear Medicine and Imaging with an H index of 15. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on radionuclide therapy, radionuclide imaging, perfusion imaging, scintigraphy, positron-emission tomography, molecular imaging. It has an SJR impact factor of 0,275 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,275.
Type: Journal
Type of Copyright: CC BY-NC-ND
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
Categories:
Radiology, Nuclear Medicine and Imaging (Q3)
Price
- €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
0,275
SJR Impact factor15
H Index43
Total Docs (Last Year)138
Total Docs (3 years)546
Total Refs106
Total Cites (3 years)131
Citable Docs (3 years)0.84
Cites/Doc (2 years)12.7
Ref/DocOther journals with similar parameters
Neuroradiology Journal Q3
Journal of Medical Radiation Sciences Q3
Cancer/Radiotherapie Q3
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique Q3
Journal of Invasive Cardiology Q3
Compare this journals
Aims and Scope
Radionuclide therapy
Radionuclide imaging
Perfusion imaging
Scintigraphy
Positron-emission tomography
Molecular imaging
Comments